PRINCIPAL FINANCIAL GROUP INC

Holdings History for Revance Therapeutics, Inc. - COM (RVNC)

Symbol: RVNC on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2024		0%	$0	0	-18,375	-100%		Q3 2024
6/30/2024	0%	0%	$47.2K	18.4K	-2,489	-11.9%	$2.57	Q2 2024
3/31/2024	0%	0%	$103K	20.9K	-248,854	-92.3%	$4.92	Q1 2024
12/31/2023	0%	0%	$2.37M	270K	-693,311	-72%	$8.79	Q4 2023
9/30/2023	0.01%	+0%	$11M	963K	+342,540	+55.2%	$11.47	Q3 2023
6/30/2023	0.01%	+0.01%	$15.7M	620K	+589,229	+1885%	$25.31	Q2 2023
3/31/2023	0%	0%	$1.01M	31.3K	-3,306	-9.56%	$32.21	Q1 2023
12/31/2022	0%	+0%	$638K	34.6K	+15,963	+85.8%	$18.46	Q4 2022
9/30/2022	0%	0%	$502K	18.6K	-290	-1.53%	$26.98	Q3 2022
6/30/2022	0%	+0%	$261K	18.9K	+6,043	+47%	$13.81	Q2 2022
3/31/2022	0%	+0%	$251K	12.9K	+913	+7.65%	$19.53	Q1 2022
12/31/2021	0%	-0.01%	$195K	11.9K	-691,506	-98.3%	$16.34	Q4 2021
9/30/2021	0.01%	+0%	$19.6M	703K	+24,812	+3.66%	$27.86	Q3 2021
6/30/2021	0.01%	+0%	$20.1M	679K	+130,338	+23.8%	$29.64	Q2 2021
3/31/2021	0.01%	+0%	$15.3M	548K	+114,515	+26.4%	$27.95	Q1 2021
12/31/2020	0.01%	0%	$12.3M	434K	-134,067	-23.6%	$28.34	Q4 2020
9/30/2020	0.01%	+0%	$14.3M	568K	+3,087	+0.55%	$25.14	Q3 2020
6/30/2020	0.01%	+0%	$13.8M	565K	+161,601	+40.1%	$24.42	Q2 2020
3/31/2020	0.01%	0%	$5.97M	403K	-13,409	-3.22%	$14.80	Q1 2020
12/31/2019	0.01%	+0%	$6.76M	417K	+93,213	+28.8%	$16.23	Q4 2019
9/30/2019	0%	+0%	$4.2M	323K	+99,788	+44.6%	$13.00	Q3 2019
6/30/2019	0%	+0%	$2.9M	224K	+109,297	+95.6%	$12.97	Q2 2019
3/31/2019	0%	+0%	$1.8M	114K	+167	+0.15%	$15.76	Q1 2019
12/31/2018	0%	0%	$2.3M	114K	-14,043	-11%	$20.13	Q4 2018
9/30/2018	0%	+0%	$3.18M	128K	+2,236	+1.78%	$24.85	Q3 2018
6/30/2018	0%	0%	$3.46M	126K	-112	-0.09%	$27.45	Q2 2018
3/31/2018	0%	0%	$3.88M	126K	-160	-0.13%	$30.80	Q1 2018
12/31/2017	0%	+0%	$4.51M	126K	+48,121	+61.6%	$35.75	Q4 2017
9/30/2017	0%	0%	$2.15M	78.1K	-3,375	-4.14%	$27.56	Q3 2017
6/30/2017	0%	+0%	$2.15M	81.4K	+83	+0.1%	$26.40	Q2 2017
3/31/2017	0%	+0%	$1.69M	81.4K	+138	+0.17%	$20.80	Q1 2017
12/31/2016	0%	+0%	$1.68M	81.2K	+861	+1.07%	$20.70	Q4 2016
9/30/2016	0%	+0%	$1.3M	80.4K	+385	+0.48%	$16.22	Q3 2016
6/30/2016	0%	0%	$1.09M	80K	-1,305	-1.61%	$13.59	Q2 2016
3/31/2016	0%	0%	$1.42M	81.3K	-476	-0.58%	$17.46	Q1 2016
12/31/2015	0%	+0%	$2.79M	81.7K	+3,481	+4.45%	$34.17	Q4 2015
9/30/2015	0%	+0%	$2.33M	78.3K	+1,502	+1.96%	$29.76	Q3 2015
6/30/2015	0%	+0%	$2.46M	76.8K	+6,125	+8.67%	$31.98	Q2 2015
3/31/2015	0%	0%	$1.46M	70.6K	-1,798	-2.48%	$20.71	Q1 2015
12/31/2014	0%	0%	$1.23M	72.4K	-178	-0.25%	$16.94	Q4 2014
9/30/2014	0%	+0%	$1.4M	72.6K	+5,581	+8.33%	$19.33	Q3 2014
6/30/2014	0%	+0%	$2.28M	67K	+7,035	+11.7%	$34.00	Q2 2014
3/31/2014	0%	+0%	$1.89M	60K	+60,000	NEW	$31.50	Q1 2014

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.